How do you pay?

How to pay the least

Cash price

$970+ for 30 tablets

Pharmacies pay about this for Ibsrela; you’d pay more.

  1. Ask your pharmacy for Ibsrela’s cash price, and one or two other pharmacies too.
  2. Ibsrela’s savings card works only with insurance from a job or one you bought.

No generic is sold yet.

Compare every option

Question
Brand nameIbsrela
Authorized generictenapanor
Regular generictenapanor
What you’d pay
At least$970for 30 tablets; pharmacies pay this
Not soldThere isn’t one
Not soldNone sold yet
Same as Ibsrela?
The original
–
–

Brand nameThe maker’s card

IBSRELA Commercial Copay Program

Savings card from Ardelyx

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a month

Sign up on ardelyx.com 

In the maker’s words

“Patients with commercial insurance pay as little as $0 per 30-day prescription fill of IBSRELA.”

From the maker’s offer on ardelyx.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Ibsrela itself, from the same company, sold without the brand name, and usually for less. For now Ibsrela is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

No generic is sold yet. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

IBSRELA is a sodium/hydrogen exchanger 3 (NHE3) inhibitor indicated for treatment of irritable bowel syndrome with constipation (IBS-C) in adults.

Source: the FDA label for Ibsrela (Ardelyx, Inc.), May 28, 2025. Full label on DailyMed 

Good to know